Table 3.
Ranking of consumption of sulphonamides and trimethoprim (ATC J01E) in the community, expressed in DDDs or packages per 1000 inhabitants per day, 20 EU/EEA countries, 2017
| Country | Bulgaria | Czechia | Latvia | Slovenia | Finland | Denmark | France | Iceland | Croatia | Greece | Portugal | Estonia | Slovakia | Lithuania | Belgium | Italy | Ireland | Sweden | Spain | Austria |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ranking for packages per 1000 inhabitants per day |
1 | 2 | 3 | – | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
|
Ranking for DDD per 1000 inhabitants per day |
5 | 4 | 6 | – | 2 | 7 | 12 | 17 | 9 | 14 | 13 | 11 | 1 | 19 | 18 | 8 | 3 | 15 | 10 | 16 |
| Number of DDD per package | 4.5 | 5.7 | 5.9 | – | 8.5 | 8.0 | 4.9 | 3.0 | 8.0 | 4.9 | 7.2 | 7.7 | 22.9 | 0.2 | 3.7 | 14.3 | 20.9 | 7.0 | 11.3 | 9.7 |
For Czechia, 2015 data are used. For Slovakia, 2016 data are used. For Cyprus and Romania, total care data, i.e. community and hospital sector combined, are used. For Slovenia, sulphonamide and trimethoprim (J01E) consumption was not reported in 2017.